Navellier & Associates Inc. Buys 3,967 Shares of The Allstate Co. (NYSE:ALL)

Navellier & Associates Inc. lifted its position in The Allstate Co. (NYSE:ALL) by 12.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 35,131 shares of the insurance provider’s stock after acquiring an additional 3,967 shares during the quarter. Allstate comprises approximately 0.8% of Navellier & Associates Inc.’s portfolio, making the stock its 26th largest holding. Navellier & Associates Inc.’s holdings in Allstate were worth $6,773,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in ALL. State Street Corp boosted its holdings in Allstate by 1.1% during the third quarter. State Street Corp now owns 11,496,306 shares of the insurance provider’s stock worth $2,190,758,000 after purchasing an additional 126,922 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Allstate by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider’s stock worth $1,178,164,000 after buying an additional 74,537 shares during the last quarter. Strategic Financial Concepts LLC grew its holdings in shares of Allstate by 15,062.3% in the fourth quarter. Strategic Financial Concepts LLC now owns 1,119,129 shares of the insurance provider’s stock valued at $215,757,000 after acquiring an additional 1,111,748 shares in the last quarter. Pathway Financial Advisers LLC grew its holdings in shares of Allstate by 18,472.5% in the third quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock valued at $199,642,000 after acquiring an additional 1,047,019 shares in the last quarter. Finally, FMR LLC lifted its holdings in Allstate by 11.8% during the third quarter. FMR LLC now owns 933,352 shares of the insurance provider’s stock worth $177,010,000 after acquiring an additional 98,179 shares during the period. Institutional investors own 76.47% of the company’s stock.

Allstate Trading Down 1.9 %

NYSE:ALL opened at $185.51 on Friday. The Allstate Co. has a 1 year low of $153.87 and a 1 year high of $209.88. The stock’s fifty day moving average price is $190.25 and its two-hundred day moving average price is $190.15. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The company has a market cap of $49.12 billion, a P/E ratio of 10.92, a P/E/G ratio of 1.05 and a beta of 0.52.

Allstate (NYSE:ALL) last released its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. As a group, analysts expect that The Allstate Co. will post 18.65 EPS for the current year.

Insider Activity

In related news, CFO Jesse E. Merten sold 40,102 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the completion of the transaction, the chief financial officer now owns 18,115 shares of the company’s stock, valued at approximately $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on ALL shares. Keefe, Bruyette & Woods upped their price objective on Allstate from $235.00 to $240.00 and gave the company an “outperform” rating in a research note on Tuesday, February 11th. Barclays decreased their price objective on shares of Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a report on Monday, January 6th. Evercore ISI upgraded shares of Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Piper Sandler increased their target price on shares of Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a research report on Tuesday, November 26th. Finally, UBS Group lifted their price target on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Allstate currently has an average rating of “Moderate Buy” and an average price target of $217.94.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.